Wound Care: Why Test?
Molecular testing personalizes the medicine of wound care. Ipsum Diagnostics not only identifies the major infecting agent but also asses the wound biome, i.e. multiple microbes living in a biofilm-based community contributing to infection and treatment failure. Their tests identify multiple bacterial and fungal species causing infection as well as antibiotic-resistant genes. The result is an accurate diagnosis, personalized treatment, and more rapid healing.
Chronic wound infections often involve multiple organisms. Polymicrobial infections are associated with inferior outcomes, however; microbial culture methods fail to identify the vast majority of bacterial and fungal species present in the wound. The presence of fungal species is not only extensive in wounds but they also play an active role in delayed healing, increased complications and poor outcomes.
Molecular testing improves antimicrobial stewardship. Ipsum Diagnostics reports antibiotic resistance genes when present. Choosing antimicrobial drugs that work will reduce treatment failure and curb the creation of drug-resistant superbugs.
Ipsum Diagnostics molecular microbial tests remove the uncertainty and delay of traditional testing and provide physicians with the most accurate information for a successful course of treatment.
Once you know the RIGHT BUG you can select the RIGHT DRUG.
Easy Collection Process
Procuring samples for wound care testing is easy. There are no special surgical procedures or storage requirements. Collection swabs and containers can be stored at room temperature. To ship, simply call Pain Rehab Products or lpsum Diagnostics to schedule a pickup. Pain Rehab Products and lpsum Diagnostics will train you and your staff on collection technique and provide all supplies for specimen collection and shipping.
lpsum Diagnostics is a leader in Directed Personalized Wound Care.
Qualitative AND Quantitative Results: Comprehensive testing identifies both bacteria and fungi species in relative quantities with antibiotic resistance markers if present. Accurate results help determine the right plan and avoid costly and ineffective treatments.
Rapid Turn-around Time Results provided as quickly as the same day sample received, in a straightforward and informative report including evidence-based treatment options, available immediately to physicians by online portal or fax. Get the answers you need to inform best practice in a timely manner.
Ispum Diagnostics’ Experienced Technical Team accredited with CLIA High-Complexity Laboratory standards include Director Henry Skelton, MD board certified in anatomical and clinical pathology and dermatopathology; Maggie Hopkins, MD MBA FASCP, board certified in clinical pathology and experienced in molecular pathology and microbiology; and Lucy Feingold Ph.D., board certified in molecular biology. With a combined 70-plus years’ experience, our team has the know-how to ensure the highest quality of testing.